Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Sekisui OSOM Flu SARS-CoV-2 Combo Control Kit

OSOM Flu SARS-CoV-2 Combo Control Kit is intended for use in external quality control with the OSOM Flu SARS-CoV-2 Combo Antigen Test Kit. For Emergency Use Authorization Only.

Supplier:  Sekisui 1079

Catalog No. 22-321-144



Add to Cart

Description

Description

  • Contains:
    • 5 - Flu A / Flu B / SARS-CoV-2 Positive Control Swab (packaged with a desiccant tablet) coated with non-infectious recombinant influenza A, influenza B, and SARS-CoV-2 containing 0.05% sodium azide
    • 5 Flu A / Flu B / SARS-CoV-2 Negative Control Swabs (packaged with a desiccant tablet) coated with nonviable Group C Streptococci containing 0.09% sodium azide
  • Intended for use in external quality control with the OSOM Flu SARS-CoV-2 Combo Antigen Test Kit
  • For Emergency Use Authorization Only
Specifications

Specifications

SARS-CoV-2, Influenza A and B
For use in external quality control with the OSOM Flu SARS-CoV-2 Combo Antigen Test Kit
Positive and Negative Lyophilized swab
Kit
Swab
Lyophilized
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit

In the USA, this product has not been FDA cleared or approved, but has been authorized by FDA under an Emergency Use Authorization. This product has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.